Literature DB >> 24777292

Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema--potential mechanisms, treatment algorithm, and case examples.

Arschang Valipour1, Dirk-Jan Slebos, Hugo G de Oliveira, Ralf Eberhardt, Lutz Freitag, Gerard J Criner, Felix J F Herth.   

Abstract

The use of endoscopically placed unidirectional valves for the treatment of emphysema is increasing. With better patient selection, there is also an increased likelihood of complications associated with the procedure, such as postprocedural pneumothorax. There is, however, little evidence of pneumothorax management in patients with severe COPD and emphysema. This report describes an expert recommendation that has been developed to outline pneumothorax management after valve placement to inform physicians and patients of the risk-benefit profile and to assist them in decision making. Skilled and aggressive pneumothorax management is necessary in this patient population, and by following these recommendations traumatic scenarios, prolonged drainage, extended hospitalizations, and/or surgery might be avoided in many cases.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24777292     DOI: 10.1159/000360642

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  27 in total

Review 1.  Clinical review: Endobronchial valve treatment for emphysema.

Authors:  Nabil Jarad
Journal:  Chron Respir Dis       Date:  2016-02-15       Impact factor: 2.444

2.  Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Authors:  Arschang Valipour; Pallav L Shah; Christophe Pison; Vincent Ninane; Wim Janssens; Thierry Perez; Romain Kessler; Gaetan Deslee; Justin Garner; Christine Abele; Jorine E Hartman; Dirk-Jan Slebos
Journal:  Respiration       Date:  2019-06-20       Impact factor: 3.580

Review 3.  Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice.

Authors:  Arschang Valipour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 4.  Complications after bronchoscopic lung volume reduction.

Authors:  Daniel Franzen; Gilles Straub; Lutz Freitag
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

6.  [Bronchoscopic lung volume reduction in emphysema without collateral ventilation : STELVIO trial].

Authors:  F J Herth; S Nitschmann
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

7.  The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema.

Authors:  Shiyue Li; Guangfa Wang; Changhui Wang; Xinglin Gao; Faguang Jin; Huaping Yang; Baohui Han; Rui Zhou; Chengshui Chen; Liangan Chen; Chunxue Bai; Huahao Shen; Felix J F Herth; Nanshan Zhong
Journal:  Respiration       Date:  2018-12-14       Impact factor: 3.580

Review 8.  Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction.

Authors:  Dirk-Jan Slebos; Pallav L Shah; Felix J F Herth; Arschang Valipour
Journal:  Respiration       Date:  2016-12-20       Impact factor: 3.580

9.  Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multicenter study.

Authors:  Alfonso Fiorelli; Antonio D'Andrilli; Michela Bezzi; Mohsen Ibrahim; Marco Anile; Daniele Diso; Giacomo Cusumano; Alberto Terminella; Valentina Luzzi; Margherita Innocenti; Mauro Novali; Emanuele Carelli; Chiara Freda; Giovanni Natale; Valentina Peritore; Camilla Poggi; Giuseppe Failla; Marco Basile; Emilia Mazzucca; Serena Conforti; Nicola Serra; Massimo Torre; Federico Venuta; Erino Angelo Rendina; Mario Santini; Claudio Andreetti
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

10.  Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.

Authors:  Ralf Eberhardt; Dirk-Jan Slebos; Felix J F Herth; Kaid Darwiche; Manfred Wagner; Joachim H Ficker; Christoph Petermann; Ralf-Harto Hübner; Franz Stanzel; Narinder S Shargill; Arschang Valipour
Journal:  Respiration       Date:  2021-07-23       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.